The Diagnostic Biomarkers and Technology Branch stimulates and supports research to develop new biomarkers, diagnostic strategies, innovative technologies and improved devices that will lead to better tools for research and to aid clinical decision-making.
For more information on cancer marker development supported by DBT, please visit Marker Discovery.
For more information on the types of technologies supported by DBT, please visit Technology Development
For information on special funding initiatives and opportunities please visit Obtaining Support for Marker Discovery and Technology Development Projects and Technology Development Initiatives.
For a list of NCI/NIH resources and information of interest to technology developers see Resources and Additional Information for Technology Developers.
If you are a Small Business investigator seeking support for a project, please visit Small Business Funding Opportunities.
Name | Title | Phone | |
---|---|---|---|
James V. Tricoli, PhD | Branch Chief | 301-402-4185 | tricolij@mail.nih.gov |
Miguel Ossandon, MS | Program Director | 301-402-4185 | ossandom@mail.nih.gov |
Brian Sorg, PhD | Program Director | 301-402-4185 | sorgbs@mail.nih.gov |
Tawnya McKee, PhD | Program Director | 301-846-1943 | mkeeta@mail.nih.gov |
Mary Mengesha | Administrative Support | 301-496-9019 | mengesham@mail.nih.gov |